Results 61 to 70 of about 5,039 (274)

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis

open access: yesParasites & Vectors, 2022
Background Orally administered fluralaner (13.64% w/w) is effective for treating canine generalized demodicosis. A study was initiated to assess the efficacy of a novel 5.46% w/w fluralaner chewable tablet formulation for monthly administration in the ...
Nadja Rohdich, Leon Meyer, Frank Guerino
doaj   +1 more source

World Association for Veterinary Dermatology Consensus Statement for Diagnosis, and Evidence‐Based Clinical Practice Guidelines for Treatment and Prevention of Canine Leishmaniosis

open access: yesVeterinary Dermatology, Volume 36, Issue 6, Page 723-787, December 2025.
Hyperkeratosis of (a) the footpads and (b) the nasal planum. ABSTRACT Background Canine leishmaniosis (CanL) due to Leishmania infantum remains common, and veterinarians do not always follow scientifically sound approaches for diagnosis, treatment and prevention. Objectives To provide consensus guidelines for diagnosis and evidence‐based guidelines for
Manolis N. Saridomichelakis   +9 more
wiley   +1 more source

Efficacy and Field Safety of Ilunocitinib for the Control of Allergic Dermatitis in Client‐Owned Dogs: A Multicenter, Double‐Masked, Randomised, Placebo‐Controlled Clinical Trial

open access: yesVeterinary Dermatology, Volume 36, Issue 6, Page 825-837, December 2025.
Background: Inhibition of the Janus kinase pathway is an established treatment for allergic dermatitis. Objective: To evaluate the efficacy and safety of ilunocitinib for control of pruritus in dogs with allergic dermatitis in a randomised, double‐masked clinical trial.
Sophie Forster   +5 more
wiley   +1 more source

Tratamiento de la demodicosis canina generalizada con dosis reducidas de ivermectina oral [PDF]

open access: yes, 1998
La administración diaria de ivermectina a dosis altas (0,6 mg/kg) es la mejor alternativa disponible para tratar aquellos casos de sarna demodécica resistente al ...
Ginel, P. J.   +2 more
core  

Demodex: the worst enemies are the ones that used to be friends

open access: yesDermatology Reports, 2022
Demodex mites are common ectoparasites of the human pilosebaceous units. Most adults are infested with Demodex mites without clinical symptoms. Demodex mite will only become a pathogenic organism when there is an abnormal increase in the number of ...
Anon Paichitrojjana
doaj   +1 more source

Facial Demodicosis-Induced Skin Hyperpigmentation in an Immunocompromised Man Treated Successfully with Ivermectin 1% Cream: A Case Report

open access: yesClinical, Cosmetic and Investigational Dermatology, 2023
Demodex folliculorum is a common ectoparasite of humans that inhabits follicular infundibulum and sebaceous ducts. Its role in various dermatological diseases is well studied. However, data on demodex-induced skin pigmentation are very limited.
Sadan Mohammed Al Harbi   +3 more
semanticscholar   +1 more source

Eficacia de la ivermectina oral en el tratamiento de la sarna demodécica canina resistente al almitraz [PDF]

open access: yes, 1994
Se describen dos casos de sarna demodécica canina resistente al amitraz, tratados con ivermectina por vía oral a dosis de 600 mcg/kg durante 3 y 5 meses respectivamente.Two cases of amitraz-resistant generalized demodicosis treated with ivermectin 600 ...
Cairó Vilagran, Jordi   +5 more
core  

Regional features of the course of demodicosis in dogs

open access: yesGSC Advanced Research and Reviews, 2023
Demodicosis is one of the most common diseases in dogs. We have analyzed the epizootological features of the course of demodectic invasion in dogs. In the process of research, territorial, age, breed, sex, seasonal features of the distribution of canine ...
Yulia Horiuk, S. Prosyanyi
semanticscholar   +1 more source

Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial

open access: yesVeterinary Dermatology, Volume 36, Issue 5, Page 647-659, October 2025.
Background – Inhibition of the Janus kinase (JAK) pathway is a well‐established option for canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, a novel JAK inhibitor for the control of pruritus and skin lesions in client‐owned dogs with cAD.
Sophie Forster   +5 more
wiley   +1 more source

Sistem Pakar Identifikasi Penyakit Kulit Anjing Menggunakan Metode Certainty Factor [PDF]

open access: yes, 2015
Dogs are common animal that found as pets in Indonesia. Indonesia as a tropical country has a high humidity, where fungi and parasites easily to multiply on animal skin. The fungi and parasites are one of the causes of dog skin diseases.
Hakim, A. M. (Arnaz)   +2 more
core  

Home - About - Disclaimer - Privacy